174 related articles for article (PubMed ID: 25028695)
21. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
22. Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions.
Yoshimura M; Tsutsui H; Ikeda N; Koizumi K
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):101-8. PubMed ID: 23474638
[TBL] [Abstract][Full Text] [Related]
23. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
Al-Shakhrah IA
Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
[TBL] [Abstract][Full Text] [Related]
24. Estimated Dose to Family Members of Patients Treated with Radioiodine.
Kochovska MZ; Jokic VS; Majstorov V; Dugonjic S
Radiat Prot Dosimetry; 2017 Apr; 174(2):250-254. PubMed ID: 27247441
[TBL] [Abstract][Full Text] [Related]
25. [Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].
Günter HH; Junker D; Schober O; Hundeshagen H
Strahlenther Onkol; 1987 Mar; 163(3):185-91. PubMed ID: 3563879
[TBL] [Abstract][Full Text] [Related]
26. Potential third-party radiation exposure from patients undergoing therapy with 131I for thyroid cancer or metastases.
D'Alessio D; Giliberti C; Benassi M; Strigari L
Health Phys; 2015 Mar; 108(3):319-25. PubMed ID: 25627943
[TBL] [Abstract][Full Text] [Related]
27. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
[TBL] [Abstract][Full Text] [Related]
28. Management of the helpless patient after radioiodine ablation therapy - are we being too strict?
Williams CE; Woodward AF
Nucl Med Commun; 2005 Oct; 26(10):925-8. PubMed ID: 16160653
[TBL] [Abstract][Full Text] [Related]
29. Measurements and prediction of the ambient dose rate from patient receiving radioiodine administration after thyroid ablation.
Kim CB; Jung JW; Jeong KH; Ahn BC; Lee HH; Lee J
Radiat Prot Dosimetry; 2012 Aug; 151(1):158-61. PubMed ID: 22171099
[TBL] [Abstract][Full Text] [Related]
30. Prediction of dose to the relatives of patients treated with radioiodine-131 using neural networks.
Ebrahimi M; Kardan MR; Changizi V; Pooya SMH; Geramifar P
J Radiol Prot; 2018 Mar; 38(1):422-433. PubMed ID: 29154258
[TBL] [Abstract][Full Text] [Related]
31. Absence of bone marrow toxicity in elderly patients treated with recombinant human thyroid-stimulating hormone and empirically dosed radioiodine for thyroid cancer.
Amdur RJ; Dan T; Mazzaferri E
Am J Clin Oncol; 2013 Aug; 36(4):348-53. PubMed ID: 22547013
[TBL] [Abstract][Full Text] [Related]
32. Use of a voxel phantom as a source and a second voxel phantom as a target to calculate effective doses in individuals exposed to patients treated with 131I.
de Carvalho AB; Hunt J; Silva AX; Garcia F
J Nucl Med Technol; 2009 Mar; 37(1):53-6. PubMed ID: 19223425
[TBL] [Abstract][Full Text] [Related]
33. Total Effective Dose Equivalent to Caregivers from Hospitalized Patients Treated with High Dose Radioiodine for Thyroid Carcinoma.
Poon N; Chaudakshetrin P; Sritongkul N; Tuntawiroon M
J Med Assoc Thai; 2016 Feb; 99(2):225-30. PubMed ID: 27249904
[TBL] [Abstract][Full Text] [Related]
34. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
Siekierzyński M
Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
[TBL] [Abstract][Full Text] [Related]
35. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
[TBL] [Abstract][Full Text] [Related]
36. Recommended restrictions after 131I therapy: measured doses in family members.
Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
Health Phys; 1999 Feb; 76(2):129-36. PubMed ID: 9929123
[TBL] [Abstract][Full Text] [Related]
37. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.
Ceccarelli C; Battisti P; Gasperi M; Fantuzzi E; Pacini F; Gualdrini G; Pierantoni MC; Luciani A; Djokich D; Pinchera A
J Nucl Med; 1999 Oct; 40(10):1716-21. PubMed ID: 10520714
[TBL] [Abstract][Full Text] [Related]
38. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
Wellner U; Eschner W; Hillger HW; Schicha H
Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
[TBL] [Abstract][Full Text] [Related]
40. Radioactivity of blood samples taken from thyroidectomized thyroid carcinoma patients after therapy with (131)I.
Larkin A; Millan E; Noz M; Wagner S; Friedman K; Blum M
Thyroid; 2011 Sep; 21(9):1009-12. PubMed ID: 21834682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]